Rectal Cancer, Version 2.2015.

Journal Article (Journal Article)

The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Rectal Cancer Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize major discussion points from the 2015 NCCN Rectal Cancer Panel meeting. Major discussion topics this year were perioperative therapy options and surveillance for patients with stage I through III disease.

Full Text

Duke Authors

Cited Authors

  • Benson, AB; Venook, AP; Bekaii-Saab, T; Chan, E; Chen, Y-J; Cooper, HS; Engstrom, PF; Enzinger, PC; Fenton, MJ; Fuchs, CS; Grem, JL; Grothey, A; Hochster, HS; Hunt, S; Kamel, A; Kirilcuk, N; Leong, LA; Lin, E; Messersmith, WA; Mulcahy, MF; Murphy, JD; Nurkin, S; Rohren, E; Ryan, DP; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Willett, CG; Gregory, KM; Freedman-Cass, D

Published Date

  • June 2015

Published In

Volume / Issue

  • 13 / 6

Start / End Page

  • 719 - 728

PubMed ID

  • 26085388

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2015.0087


  • eng

Conference Location

  • United States